MLP Saglik Hizmetleri A.S. (MPARK) Fair Value & Analysis
Healthcare · TR · Market cap 76.2B TRY
Fair value as of: Aug 1, 2026
From 26 valuation models · updated today
Share price −5.2% over the past month.
What matters now
- Solid quality (52/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (351.34 TRY to 799.88 TRY) leaves room in how you read the outcome.
Price vs Fair Value (12 months)
12‑month range 308.00 TRY – 495.00 TRY · fair‑value band 351.34 TRY – 799.88 TRY · the 405.00 TRY price screens below the 639.90 TRY fair value. As of Aug 1, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
MLP Saglik Hizmetleri A.S. (MPARK) currently trades at 405.00 TRY, while our model-based Fair Value estimate is 639.90 TRY, implying the stock looks roughly 58.0% undervalued today. We read business quality at 52/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, MLP Saglik Hizmetleri A.S. generated revenue of 55.1B TRY at a net margin of 10.1%. Revenue grew 5.7% year over year. It earns a return on equity of 20.6%. Net debt stands at 4.8B TRY. Fundamentals as of Aug 1, 2026
Our scenario range runs from 351.34 TRY (bear case) to 799.88 TRY (bull case); at 405.00 TRY, the current price sits within that range. The share trades about 21% below its 52-week high and 33% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -21% fair-value upside, at 58%, MPARK screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 1, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
MLP Saglik Hizmetleri A.S. provides healthcare services in Turkey and internationally. It provides treatment, laboratory, and hospital services, as well as trades in medical products. The company was formerly known as Medical Park. MLP Saglik Hizmetleri A.S. was founded in 1993 and is based in Istanbul, Turkey.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
MLP Saglik Hizmetleri A.S. reported revenue of 55.1B TRY in FY2025 versus 5.8B TRY in FY2021, a compound +75.6%/yr. Reported net income was 5.5B TRY in FY2025, compounding +109.0%/yr from FY2021.
Is MPARK fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 1, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$95.75 | R$123.65 | +29% |
| Fresenius SE FRE | €37.69 | €30.03 | -20% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.50 | R$46.04 | +42% |
| DaVita Inc DVAI34 | R$1,081 | R$207.69 | -81% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,305 | ₹2,546 | -69% |
| Fresenius Medical Care AG FMSC34 | R$120.84 | R$36.43 | -70% |
| Aier Eye Hospital Group 300015 | ¥8.54 | ¥6.73 | -21% |
Compare MLP Saglik Hizmetleri A.S. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is MLP Saglik Hizmetleri A.S. (MPARK) overvalued or undervalued?
What is the fair value of MPARK?
What is the quality score of MPARK?
What is the revenue of MLP Saglik Hizmetleri A.S. (MPARK)?
What is the net profit margin of MPARK?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track MLP Saglik Hizmetleri A.S. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.